Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors

NCT07160335

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations
  • Oncology Physicians Network (OPN) - Glendale Glendale, California, United States
  • Oncology Physicians Network (OPN)- Los Alamitos Los Alamitos, California, United States
  • HCA Los Angeles, California, United States
  • Los Angeles Cancer Network Los Angeles, California, United States
View all 69 locations
View Trial Details
Active, not recruiting

A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features

NCT06564844

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +12 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Glendale, California, United States
  • Research Site Los Angeles, California, United States
View all 90 locations
View Trial Details
Active, not recruiting

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

NCT04929041

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +18 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 169 locations
View Trial Details
Active, not recruiting

Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC

NCT03965468

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Istituto Oncologico Veneto - Irccs Padova, Italy
  • IRCCS Istituto Nazionale Tumori Regina Elena Roma, Italy
  • Maastricht University Medical Center Maastricht, Netherlands
  • Erasmus Medical Centre Rotterdam, Netherlands
View all 14 locations
View Trial Details
Active, not recruiting

A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC

NCT06745323

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut Plainville, Connecticut, United States
  • AdventHealth Hematology and Oncology Orlando, Florida, United States
  • City of Hope Chicago Rockford, Illinois, United States
View all 78 locations
View Trial Details
Active, not recruiting

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

NCT06074588

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCLA Hematology/Oncology - Santa Monica ( Site 0023) Los Angeles, California, United States
  • Mayo Clinic in Florida-Mayo Clinic Comprehensive Cancer Center ( Site 0001) Jacksonville, Florida, United States
  • Mid Florida Hematology and Oncology Center ( Site 0005) Orange City, Florida, United States
  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0003) Marietta, Georgia, United States
View all 195 locations
View Trial Details
Active, not recruiting

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

NCT05853575

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
Locations
  • Local Institution - 101 Santa Rosa, California, United States
  • Local Institution - 105 Kansas City, Missouri, United States
  • Local Institution - 100 Durham, North Carolina, United States
  • Local Institution - 106 Dallas, Texas, United States
View all 98 locations
View Trial Details
Active, not recruiting

A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies

NCT06120075

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Research Site Denver, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Grand Rapids, Michigan, United States
View Trial Details

Related conditions